Product
Nirmatrelvir-Ritonavir
2 clinical trials
2 indications
Indication
COVID-19Indication
Hospitalized PatientsClinical trial
A Prospective Multicenter, Randomized, Controlled Clinical Trial of the Safety and Efficacy of Azvudine vs. Nirmatrelvir-Ritonavir in Hospitalized Patients With Moderate to Severe COVID-19 InfectionStatus: Recruiting, Estimated PCD: 2023-05-21
Clinical trial
Appropriate Evaluation of Antiviral Therapy With Nirmatrelvir-ritonavir in Hospitalized Patients: a Multicenter Retrospective Study in ChinaStatus: Recruiting, Estimated PCD: 2023-04-01